IQOS becomes first electrically heated tobacco product to qualify for sale in U.S
Issued by Tincan PR - May 17th, 16:29
The U.S. Food and Drug Administration (FDA) confirmed that IQOS, Philip Morris International’s electrically heated tobacco system, is appropriate for the protection of public health and has authorized it for sale in the United States. FDA’s decision follows its comprehensive assessment of PMI’s premarket tobacco product applications (PMTAs) filed with the Agency in 2017.
Unlike cigarettes, the IQOS system heats — but does not burn — tobacco. It is the first electrically heated tobacco product to qualify for sale in the U.S. pursuant to the 2009 law that empowers FDA to regulate tobacco products, including through oversight of innovative products.
Commenting on the FDA’s announcement, Andrй Calantzopoulos, PMI’s Chief Executive Officer, said:
“The FDA’s decision to authorize IQOS in the U.S. is an important step forward for the approximately 40 million American men and women who smoke. Some will quit. Most won’t, and for them, IQOS offers a smoke-free alternative to continued smoking."
In just two years, 7.3 million people around the world have abandoned cigarettes and switched completely to IQOS. The decision by the FDA makes this opportunity available to American adult smokers.
"All of us at PMI are determined to replace cigarettes with smoke-free alternatives that combine sophisticated technology and intensive scientific validation. FDA’s announcement is a historic milestone.”
He added, “The order sets out clear commercialization guidelines, including marketing requirements, that maximize the opportunity for adults to switch from cigarettes while minimizing unintended use. We fully support this objective. FDA has set a high standard and we look forward to working with them to implement the order so that IQOS is reaching the right audience—current adult smokers."
PMI will bring IQOS to the U.S. market through an exclusive license with Altria Group, Inc., whose subsidiary Philip Morris USA has the market expertise and infrastructure to ensure a successful launch. PM USA is ready to deploy its initial lead market plans for IQOS.
PMI submitted a comprehensive body of scientific evidence in support of the PMTAs and of the parallel applications for IQOS as a “Modified Risk Tobacco Product”, which FDA continues to review.
Philip Morris expands its retail footprint with first SA store
26/07/2019 - 11:06
Philip Morris South Africa (PMSA), an affiliate of the leading international tobacco company Philip Morris International (PMI), opens its first IQOS flagship store in Sandton City, adding to its current retail footprint of 11 kiosks in leading malls across Gauteng, Western Cape, and Kwazulu-Natal.
Zimbabwe's farmers smell the tea and coffee
14/06/2019 - 09:50
Farmers in Zimbabwe’s Eastern Highlands are smelling the tea and coffee.
New tobacco rules will choke healthier products, says Philip Morris
03/12/2018 - 11:18
Philip Morris International, one of the biggest tobacco companies in the world, sees SA’s mooted tobacco regulations as an impediment to its plan to phase out its cigarette brands, such as Marlboro, in favour of healthier alternatives.
R10 illegal cigarette pack becomes SA's top seller
29/11/2018 - 08:23
Research house Ipsos said that South Africa has become the first country in the world to allow an illegal cigarette brand to become a top seller, after Gold Leaf Tobacco’s RG brand became the top-selling brand in the country overall, overtaking all legal brands.
Illicit tobacco sales will cost SA R7bn this year, says Tisa
06/07/2018 - 13:21
Tobacco Institute report claims suspended SARS commissioner Tom Moyane turned a blind eye to the illicit cigarette industry.